BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33448156)

  • 1. Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma.
    Fomchenko EI; Reeves BC; Sullivan W; Marks AM; Huttner A; Kahle KT; Erson-Omay EZ
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1597. PubMed ID: 33448156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    Ishi Y; Yamaguchi S; Hatanaka KC; Okamoto M; Motegi H; Kobayashi H; Terasaka S; Houkin K
    J Neurosurg; 2020 Feb; 134(3):733-741. PubMed ID: 32059187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.
    Lehtinen B; Raita A; Kesseli J; Annala M; Nordfors K; Yli-Harja O; Zhang W; Visakorpi T; Nykter M; Haapasalo H; Granberg KJ
    BMC Cancer; 2017 May; 17(1):310. PubMed ID: 28468611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.
    Ryan MR; Sohl CD; Luo B; Anderson KS
    Mol Cancer Res; 2019 Feb; 17(2):532-543. PubMed ID: 30257990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
    Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T
    J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma.
    Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and global genomic copy number alterations of pilomyxoid astrocytoma in the hypothalamus/optic pathway: comparative analysis with pilocytic astrocytoma using array-based comparative genomic hybridization.
    Jeon YK; Cheon JE; Kim SK; Wang KC; Cho BK; Park SH
    Mod Pathol; 2008 Nov; 21(11):1345-56. PubMed ID: 18622384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
    Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
    Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.
    Rivera B; Gayden T; Carrot-Zhang J; Nadaf J; Boshari T; Faury D; Zeinieh M; Blanc R; Burk DL; Fahiminiya S; Bareke E; Schüller U; Monoranu CM; Sträter R; Kerl K; Niederstadt T; Kurlemann G; Ellezam B; Michalak Z; Thom M; Lockhart PJ; Leventer RJ; Ohm M; MacGregor D; Jones D; Karamchandani J; Greenwood CM; Berghuis AM; Bens S; Siebert R; Zakrzewska M; Liberski PP; Zakrzewski K; Sisodiya SM; Paulus W; Albrecht S; Hasselblatt M; Jabado N; Foulkes WD; Majewski J
    Acta Neuropathol; 2016 Jun; 131(6):847-63. PubMed ID: 26920151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
    Jones DT; Hutter B; Jäger N; Korshunov A; Kool M; Warnatz HJ; Zichner T; Lambert SR; Ryzhova M; Quang DA; Fontebasso AM; Stütz AM; Hutter S; Zuckermann M; Sturm D; Gronych J; Lasitschka B; Schmidt S; Seker-Cin H; Witt H; Sultan M; Ralser M; Northcott PA; Hovestadt V; Bender S; Pfaff E; Stark S; Faury D; Schwartzentruber J; Majewski J; Weber UD; Zapatka M; Raeder B; Schlesner M; Worth CL; Bartholomae CC; von Kalle C; Imbusch CD; Radomski S; Lawerenz C; van Sluis P; Koster J; Volckmann R; Versteeg R; Lehrach H; Monoranu C; Winkler B; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; Ebinger M; Schuhmann MU; Cho YJ; Pomeroy SL; von Deimling A; Witt O; Taylor MD; Wolf S; Karajannis MA; Eberhart CG; Scheurlen W; Hasselblatt M; Ligon KL; Kieran MW; Korbel JO; Yaspo ML; Brors B; Felsberg J; Reifenberger G; Collins VP; Jabado N; Eils R; Lichter P; Pfister SM;
    Nat Genet; 2013 Aug; 45(8):927-32. PubMed ID: 23817572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric cerebellar pilomyxoid-spectrum astrocytomas.
    Forbes JA; Mobley BC; O'Lynnger TM; Cooper CM; Ghiassi M; Hanif R; Pearson MM
    J Neurosurg Pediatr; 2011 Jul; 8(1):90-6. PubMed ID: 21721894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
    Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
    Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate pilomyxoid astrocytoma and diencephalic syndrome: imaging findings.
    Nakamura OK; Pinho Mda C; Odone Filho V; Rosemberg S
    Einstein (Sao Paulo); 2012; 10(2):236-8. PubMed ID: 23052462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilomyxoid astrocytomas: a short review.
    Kulac I; Tihan T
    Brain Tumor Pathol; 2019 Apr; 36(2):52-55. PubMed ID: 30945015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous hemorrhage associated with a pilomyxoid astrocytoma. Case report.
    Gottfried ON; Fults DW; Townsend JJ; Couldwell WT
    J Neurosurg; 2003 Aug; 99(2):416-20. PubMed ID: 12924720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.
    Yamada S; Nobusawa S; Yamazaki T; Teranishi T; Watanabe S; Murayama K; Ohba S; Okabe A; Sakurai K; Urano M; Tsukamoto T; Yokoo H; Hirose Y; Abe M
    Pathol Int; 2019 Jun; 69(6):372-377. PubMed ID: 31218776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into resistance mechanisms of AZD4547 and E3810 to FGFR1 gatekeeper mutation via theoretical study.
    Liang D; Chen Q; Guo Y; Zhang T; Guo W
    Drug Des Devel Ther; 2017; 11():451-461. PubMed ID: 28255231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.
    Engelhardt S; Behling F; Beschorner R; Eckert F; Kohlhof P; Tatagiba M; Tabatabai G; Schuhmann MU; Ebinger M; Schittenhelm J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):857-866. PubMed ID: 35018490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.